Patent US2253864A successfully refreshed from Google Patents.
US4840893A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Electrochemical assay for nucleic acids and nucleic acid probes
Assignee: Genetics International Inc
•
Filing: 1984-12-14
•
Granted: 1989-06-20
•
Expires: 2004-12-14
Abstract
Abstract The present invention discloses an assay for nucleic acid which comprises the steps of; (a) providing a probe material comprising; (i) a sequence of nucleic acids complementary to a given target sequence and, (ii) a first ligand chemically linked thereto and capable of a specific binding reaction with an antiligand; (b) contacting the said probe material with an assay system comprising: (i) a suitable mediator, enzyme, substrate system capable of transferring charge to an electrode surface when the enzyme is catalytically active, and; (ii) a second ligand chemically linked to one of said mediator, enzyme or substrate, wherein the second ligand is capable of a competitive binding reaction with the antiligand, and; (iii) the said antiligand, Whereby the said first ligand competes with the said second ligand in a specific binding reaction with the antiligand, and; (c) contacting the above system with a solution suspected of containing the said target sequence whereby the binding of any of the said target sequence present to the probe affects the availability of the first ligand and therefore alters the rate of charge transfer to the electrode.
Inventors
- 👤 Hugh A. O. Hill
- 👤 Susan I. Libor
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 12:56
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/581; C; C12; C12Q; C12Q1/00; C12Q1/001; C12Q1/004; C12Q1/54; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6825; G01N33/53; G01N33/543; G01N33/54366; G01N33/54373; G01N33/5438; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/817; Y10S436/00; Y10S436/806; Y10S436/904
Claims Analysis
Total Claims: 51
Claim 1
Independent Claim
237 words
An assay for determining a target nucleic acid sequence which comprises the steps of: (a) providing a probe material comprising, (i) a sequence of nucleic acids complementary to a given target sequence and, (ii) a first ligand chemically linked thereto and capable of a specific binding reaction with an antiligand; (b) contacting the said probe material with an assay system comprising, (i) a mediator, enzyme, substrate system capable of transferring charge to an electrode surface when the enzyme is catalytically active, and (ii) a second ligand chemically linked to one of said mediator, enzyme or substrate, wherein the second ligand is capable of competing with the first ligand for binding with the antiligand, and (iii) said antiligand; whereby said first ligand competes with said second ligand in a specific binding reaction with the antiligand, the extent of binding of said second ligand to said antiligand being reflected in the charge which said system transfers to said electrode surface; (c) contacting the above system with a solution suspected of containing the said target sequence whereby the binding of any of the said target sequence present in the solution to the probe affects the availability of the first ligand to compete with said second ligand to bind said antiligand and therefore alters the rate of charge transfer to the electrode and (d) measuring said charge transfer and relating said measurement to the determination of said target nucleic acid sequence.
Claim 2
Dependent Claim
237 words
An assay for determining a target nucleic acid sequence which comprises the steps of: (a) providing a probe material comprising, (i) a sequence of nucleic acids complementary to a given target sequence and, (ii) a first ligand chemically linked thereto and capable of a specific binding reaction with an antiligand; (b) contacting the said probe material with an assay system comprising, (i) a mediator, enzyme, substrate system capable of transferring charge to an electrode surface when the enzyme is catalytically active, and (ii) a second ligand chemically linked to one of said mediator, enzyme or substrate, wherein the second ligand is capable of competing with the first ligand for binding with the antiligand, and (iii) said antiligand; whereby said first ligand competes with said second ligand in a specific binding reaction with the antiligand, the extent of binding of said second ligand to said antiligand being reflected in the charge which said system transfers to said electrode surface; (c) contacting the above system with a solution suspected of containing the said target sequence whereby the binding of any of the said target sequence present in the solution to the probe affects the availability of the first ligand to compete with said second ligand to bind said antiligand and therefore alters the rate of charge transfer to the electrode and (d) measuring said charge transfer and relating said measurement to the determination of said target nucleic acid sequence.
Claim 3
Dependent Claim
12 words
The assay of claim 1, wherein the nucleic acid is deoxyribonucleic acid.
Claim 4
Dependent Claim
12 words
The assay of claim 1, wherein the nucleic acid is ribonucleic acid.
Claim 5
Dependent Claim
72 words
The assay of claim 1, wherein the specific binding reaction between either the first or the second ligand on the one hand and the antiligand on the other hand is characteristic of the specific binding reaction between a pair of reagents or derivatives thereof selected from the group of pairs consisting of: biotin and avidin, antigen and antibody, hormone and receptor, lectin and carbohydrate, cofactor and enzyme, and complementary nucleic acid strands.
Claim 6
Dependent Claim
28 words
The assay of claim 4, wherein both the first ligand and the second ligand are biotin or derivatives thereof and the antiligand is avidin or a derivative thereof.
Claim 7
Dependent Claim
12 words
The assay of claim 1, wherein the mediator is an organometallic compound.
Claim 8
Dependent Claim
38 words
The assay of claim 6, wherein the mediator comprises at least one organic ring, which is characterised by at least two double bonds that are conjugated and a metal atom in electron-sharing contact with each of the rings.
Claim 9
Dependent Claim
12 words
The assay of claim 7, wherein the metal is a transition metal.
Claim 10
Dependent Claim
19 words
The assay of claim 8, wherein the metal is selected from the group consisting of iron, chromium and ruthenium.
Claim 11
Dependent Claim
11 words
The assay of claim 9, wherein the mediator is a ferrocene.
Claim 12
Dependent Claim
26 words
The assay of claim 1, wherein the mediator is selected from the group consisting of viologens, poly-viologens, phenazines, ferricyanide and derivatives thereof, metalloporphyrins and one-dimensional conductors.
Claim 13
Dependent Claim
11 words
The assay of claim 1, wherein the mediator is a carboborane.
Claim 14
Dependent Claim
12 words
The assay of claim 1, wherein the mediator is a ruthenium compound.
Claim 15
Dependent Claim
32 words
The assay of claim 10, wherein the mediator is selected from the group consisting of: ferrocene; chloroferrocene; methyl-trimethylaminoferrocene; 1,1-dimethylferrocene; 1,1'-dicarboxyferrocene; vinylferrocene; trimethylaminoferrocene; 1,1'dimethylferrocene; polyvinylferrocene; ferrocene monocarboxylic acid; hydroxyethylferrocene; acetoferrocene; and 1,1'-bishydroxymethyl ferrocene.
Claim 16
Dependent Claim
11 words
The assay of claim 11, wherein the mediator is a cytochrome.
Claim 17
Dependent Claim
10 words
The assay of claim 15, wherein the mediator is cytochrome-C.
Claim 18
Dependent Claim
10 words
The assay of claim 11, wherein the mediator is 7,7,8,8-tetracyano-p-quinodimethane.
Claim 19
Dependent Claim
15 words
The assay of claim 1, wherein the mediator is confined to an electrically conductive surface.
Claim 20
Dependent Claim
13 words
The assay of claim 1, wherein the enzyme is a non-oxygen specific flavoprotein.
Claim 21
Dependent Claim
57 words
The assay of claim 19, wherein said flavo-protein is selected from the group consisting of methanol dehydrogenase (EC 1.1.99.8) pyruvate oxidase (EC 1.2.3.3), xanthine oxidase (EC 1.2.3.2.2), sarcosine oxidase (EC 1.5.3.1), lipoamide dehydrogenase (EC 1.8.1.4), glutathione reductase (EC 1.6.4.2), carbonmonoxide oxido-reductase (EC 1.2.99.2), glucose oxidase, glycolate oxidase (EC 1.1.3.1) L-amino acid oxidase (EC 1.4.3.2) and lactate oxidase.
Claim 22
Dependent Claim
11 words
The assay of claims 1, wherein the enzyme is a quinoprotein.
Claim 23
Dependent Claim
22 words
The assay of claim 21, wherein said quino-protein is selected from the group consisting of glucose dehydrogenase, alcohol dehydrogenase and methanol dehydrogenase.
Claim 24
Dependent Claim
15 words
The assay of claim 1, wherein the enzyme is confined to an electrically conductive surface.
Claim 25
Dependent Claim
12 words
The assay of claim 1, wherein the enzyme is a haem-containing enzyme.
Claim 26
Dependent Claim
24 words
The assay of claim 24, wherein the haem-containing enzyme is chosen from the group consisting of lactate dehydrogenase yeast cytochrome-C peroxidase and horseradish peroxidase.
Claim 27
Dependent Claim
10 words
The assay of claim 1, wherein the enzyme is cuproprotein.
Claim 28
Dependent Claim
11 words
The assay of claim 26, wherein the cuproprotein is galactose oxidase.
Claim 29
Dependent Claim
27 words
The assay of claim 1, wherein the electrode is made of a material chosen from the group consisting of; gold, platinum, silver, carbon or a one-dimensional conductor.
Claim 30
Independent Claim
129 words
A method of assay for determining a target nucleic acid sequence comprising: (a) providing, (i) an electrode in contact with an enzyme and a substrate of the enzyme, and a mediator compound associated with the enzyme to transfer charge from the enzyme to the electrode as the conversion of substrate into product proceeds, and (ii) a probe nucleic acid sequence complementary to said target sequence which is linked to either the enzyme or the mediator compound; (b) measuring a modification in the activity of the enzyme and the mediator compound and hence the quantity of charge being transferred to the electrode resulting from the binding of said target sequence to the probe nucleic acid sequence, and (c) relating said measurement to the determination of said target nucleic acid sequence.
Claim 31
Independent Claim
129 words
A method of assay for determining a target nucleic acid sequence comprising: (a) providing, (i) an electrode in contact with an enzyme and a substrate of the enzyme, and a mediator compound associated with the enzyme to transfer charge from the enzyme to the electrode as the conversion of substrate into product proceeds, and (ii) a probe nucleic acid sequence complementary to said target sequence which is linked to either the enzyme or the mediator compound; (b) measuring a modification in the activity of the enzyme and the mediator compound and hence the quantity of charge being transferred to the electrode resulting from the binding of said target sequence to the probe nucleic acid sequence, and (c) relating said measurement to the determination of said target nucleic acid sequence.
Claim 32
Dependent Claim
25 words
The assay of claim 29, wherein the mediator compound, is selected from the group consisting of; transition metal compounds, metalloporphyrins, phenazines, carbon-boron compounds and viologens.
Claim 33
Dependent Claim
12 words
The assay of claim 30, wherein the mediator compound is biotin-labeled cytochrome-C.
Claim 34
Dependent Claim
32 words
The assay of claim 30, wherein said mediator is biotin labeled and either avidin or streptavidin is added and binds to the mediator, thereby reducing the transfer of charge to the electrode.
Claim 35
Dependent Claim
21 words
The assay of claim 29, wherein the electrode detects and measures, in the presence of a mediator, an enzyme-complex catalysed reaction.
Claim 36
Dependent Claim
13 words
The assay of claim 33, wherein the enzyme complex comprises a biotin-peroxidase-avidin complex.
Claim 37
Dependent Claim
20 words
The assay of claim 34, wherein the enzyme complex is capable of binding further biotin or biotin labeled nucleic acid.
Claim 38
Dependent Claim
26 words
The assay of claim 31, wherein either avidin or streptavidin is added and binds to the mediator, thereby reducing the transfer of charge to the electrode.
Claim 39
Dependent Claim
20 words
The assay of claim 31, wherein the electrode detects and measures, the presence of a mediator, an enzyme-complex catalysed reaction.
Claim 40
Dependent Claim
74 words
A nucleic acid probe for establishing the presence or copy number of a given target sequence in a single-stranded nucleic acid molecule, said nucleic acid probe being linked to (a) either a metallocene mediator compound or an enzyme electrochemically coupled to an electrode by a metallocene mediator compound, and, (b) biotin, wherein binding of the probe nucleic acid to the target sequence modifies the electrochemical coupling between the metallocene mediator compound and the enzyme.
Claim 41
Dependent Claim
74 words
A nucleic acid probe for establishing the presence or copy number of a given target sequence in a single-stranded nucleic acid molecule, said nucleic acid probe being linked to (a) either a metallocene mediator compound or an enzyme electrochemically coupled to an electrode by a metallocene mediator compound, and, (b) biotin, wherein binding of the probe nucleic acid to the target sequence modifies the electrochemical coupling between the metallocene mediator compound and the enzyme.
Claim 42
Dependent Claim
15 words
The nucleic acid probe of claim 38, wherein the mediator is immobilized on a surface.
Claim 43
Dependent Claim
12 words
The nucleic acid probe of claim 39, wherein the surface comprises nitrocellulose.
Claim 44
Dependent Claim
38 words
A nucleic acid probe comprising: (a) a nucleic acid strand complementary to a target nucleic acid sequence, and (b) a metallocene mediator chemically linked thereto, wherein said mediator transfers charge from a catalytically active enzyme to an electrode.
Claim 45
Dependent Claim
38 words
A nucleic acid probe comprising: (a) a nucleic acid strand complementary to a target nucleic acid sequence, and (b) a metallocene mediator chemically linked thereto, wherein said mediator transfers charge from a catalytically active enzyme to an electrode.
Claim 46
Dependent Claim
25 words
The probe of claim 41, wherein the mediator compound, is selected from the group consisting of; transition metal compounds, metalloporphyrins, phenazines, carbon-boron compounds and viologens.
Claim 47
Dependent Claim
10 words
The probe of claim 42, wherein the mediator is cytochrome-C.
Claim 48
Dependent Claim
10 words
The probe of claim 42, wherein the mediator is ferrocene.
Claim 49
Dependent Claim
12 words
The probe of claim 42, wherein the mediator is a ruthenium compound.
Claim 50
Dependent Claim
16 words
The probe of claim 45, wherein the mediator comprises [Ru(NH 3 ) 5 py] 2+ .
Claim 51
Dependent Claim
68 words
A kit of reagents for use in an assay to determine a target nucleic acid sequence comprising the nucleic acid probe of claim 41; an enzyme electrochemically coupled to an electrode by a mediator linked to said nucleic acid probe; and a substrate of said enzyme, wherein conversion of said substrate to product by said enzyme associated with said mediator transfers charge from said enzyme to said electrode.
References Cited (Backward Citations)
US4233144A
Cited
US4287300A
Cited
EP0078636A1
Cited
EP0125139A2
Cited
US4711245A
Cited
EP0150999A2
Cited
US4591550A
Cited
US4704353A
Cited
US4563417A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-06-19 | 1992-12-19 | 1993-06-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-06-19 | 1996-12-19 | 1997-06-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-06-19 | 2000-12-19 | 2001-06-20 | $7700.00 | Window Closed / Lapsed |